Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.
Alloy Therapeutics has raised $40.0M in total funding. The most recent round was Series E. The last funding was announced in April 2026.
Alloy Therapeutics's investors include Gaingels, Founders Fund, 8VC, JIC Venture Growth Investments, Bossa Invest.
Alloy Therapeutics is headquartered in Waltham, United States.
Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.
Alloy Therapeutics is at the Series E stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alloy Therapeutics — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/alloy-therapeutics. Accessed September 2, 2026.
VCBacked. (2026). Alloy Therapeutics — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/alloy-therapeutics
{{cite web |title=Alloy Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alloy-therapeutics |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated